CER-001
id:
cer-001-169-7897129
title:
CER-001
text:
CER-001 is a recombinant high-density lipoprotein (HDL) mimetic that has orphan drug status. It is in early-stage clinical trials for the potential treatment of hypoalphalipoproteinaemia, acute coronary syndrome (ACS), acute kidney injury (AKI), atherosclerosis and lecithin cholesterol acyltransferase (LCAT) deficiency. CER-001 is also under investigation as possible agent for treating hyperinflammatory states based on lipid profile alterations due to COVID-19.
brand slug:
wiki
category slug:
encyclopedia
description:
High-density lipoprotein mimetic
original url:
https://en.wikipedia.org/wiki/CER-001
date created:
2024-03-09T14:50:28Z
date modified:
2024-08-31T15:39:30Z
main entity:
{"identifier":"Q128475000","url":"https://www.wikidata.org/entity/Q128475000"}
image:
fields total:
13
integrity:
15